logo
16:01 Mar 06

Trident Lifeline Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
267.95
-0.05 (-0.02%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Trident Lifeline Ltd. Financials

Trident Lifeline Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
267.95
-0.05 (-0.02%)
16:01 Mar 06
Quality
image/svg+xml

36/100
Medium Financial Strength

Valuation
image/svg+xml

36/100
Mid Valuation

Technical

47/100
Technically Neutral

Strength

4

Weakness

8

Opportunity

0

Threats

0

18.22 %

ROE %

7.53 %

ROA %

0.00

EPS

56.05

BVPS

13.50 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
21.77 31.69 44.63 86.96 111.72
Operating Expenses +
19.01 25.44 36.44 72.1 91.37
Raw Material
14.69 23.12 30.58 44.85 60.05
Increase Decrease in Cost
-0.46 -2.89 -1.23 0.71 -3.52
Other Manufacturing Expense
1.17 2.36 2.72 6.41 0
Employee Cost
1.19 1.61 2.4 12.09 15.83
Miscellaneous Expenses
11.62 23.1 20.89 11.64 19.01
Operating Profit
2.76 6.25 8.19 14.86 20.35
Other Income
0.6 1.16 2.08 8.23 9.56
Depreciation
0.2 0.36 0.97 5.49 7.16
Interest
0.1 0.47 0.6 3.99 5.11
Profit before tax and exceptio..
3.06 6.58 8.7 13.61 17.64
Exceptional Items
0 0 0 0 0
PBT
3.06 6.58 8.7 13.61 17.64
Provision for Taxation
0.78 0.56 2.76 3.12 3.68
Net Profit
2.28 6.02 5.94 10.49 13.96
NET Profit after MI
2.25 6.02 6.34 11.75 12.98
EPS
3.94 6.23 5.52 10.22 12.54
Operating Profit Margin (%)
12.68 19.72 18.35 17.09 18.22
Net Profit Margin (%)
10.34 19 14.21 13.51 11.62

Trident Lifeline Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 64.10 63.10 63.00 63.00 63.00 63.00
FII 7.00 7.70 7.20 6.60 6.10 6.10
Public 0.40 0.40 0.40 0.10 0.00 0.00
Others 28.50 28.80 29.40 30.30 30.90 30.90
Shareholder Shares Holding %
Research 360 logo
Download Our App On: